SancyALeachmanMD, PhD, FAAD

Dermatologic Surgery, Pediatric Dermatology

Professor, Dermatology, Oregon Health & Science University

Dr. Leachman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3303 S Bond Ave
Portland, OR 97239
Phone+1 503-418-3376

Fax+1 503-494-6968

I am a Board Certified Dermatologist specializing in the care of Melanoma with a sub-specialty in familial/hereditary melanoma and melanoma genetics. I am the Principal Investigator for the War On Melanoma, a melanoma early detection program. I am also Chair of the Department of Dermatology and Director of the Melanoma and Skin Cancer Program at Knight Cancer Institute at Oregon Health and Science University.

Yale-New Haven Medical CenterResidency, Dermatology, 1994 - 1997
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1993 - 1994
University of Texas Southwestern Medical SchoolClass of 1993

John D. Gray Endowed Chair in Melanoma Research Knight Cancer Institute at OHSU
Career Achievement Award & Aaron Lerner Lectureship Pan American Society for Pigment Cell Research, 2021
Top Doctor Portland Monthly, 2017-2021
Regional Top Doctor Castle Connolly, 2003-2021
Dermatology Teacher of the Year OHSU Department of Dermatology Residency Program, 2019
Estela Medrano Memorial Award Society for Melanoma Research, 2016
Tom C. Mathews Jr. Familial Melanoma Research Endowment Huntsman Cancer Institute at University of Oregon, 2001-2013
Clinical Scientist Development Award Doris Duke Charitable Foundation, 2000-2004
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita Start of enrollment: 2008 Jan 01
Completed
Phase 1
At-Home Dermoscopy Artificial Intelligence Start of enrollment: 2025 Jan 31
Recruiting
Not Applicable
Roles: Contact, Principal Investigator

PubMed

59 citations
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit
Douglas Grossman, Nwanneka Okwundu, Edmund K. Bartlett, Michael A. Marchetti, Megan Othus
JAMA Dermatology. 2020-09-01
95 citations
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
Jonathan S. Zager, Brian R. Gastman, Sancy A. Leachman, Rene Gonzalez, Martin D. Fleming
BMC Cancer. 2018-02-05
13 citations
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry
JAMA Dermatology. 2023-05-01

Journal Articles

Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians
Laura K Ferris, Natalia Jaimes, John C Kawaoka, Caroline C Kim, Sancy A Leachman, Patricia Lucey, Michael A Marchetti, Ashfaq A Marghoob, Edward Prodanovic, Elizabeth ..., JAMA Dermatology
Prognostic Gene Expression Profiling in Cutaneous Melanoma
Douglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology

Lectures

Melanoma: The Future is Now
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
In Vitro Behavior and UV Response of Melanocytes Derived from Carriers of CDKN2A Mutations and MC1R Variants
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 2/28/2019

OHSU Dermatologists Set New Record for Finding Smallest Skin CancerMay 19th, 2023
OHSU Dermatologists Detect the World’s Smallest Skin CancerMay 1st, 2023
Hottest Topics of the 2023 AAD Annual MeetingMarch 27th, 2023
Join now to see all

Impact Of Melanoma Genetic Testing On Health Cognitions And Prevention BehaviorsNational Cancer Institute2011–2012
Impact Of MC1R Functional Variants On The DNA Damage Response Of Human MelanocyteNational Institute Of Environmental Health Sciences2009–2012
Phase IB Trial Of Td101 Sirna For Pachyonychia Congenita (Ind 77,504, 12-03-07)Food And Drug Administration2008–2009
Familial Melanoma Research Clinic (FMRC)National Center For Research Resources2004–2008

Director, Melanoma & Skin Cancer Research ProgramDr. Leachman’s career has been devoted to the application of science to medicine, particularly molecular genetics. Her focus has been on human genetic skin disorders and melanoma. She has incorporated methods and tools across basic and clinical science, population science and public health.2013 - Present